BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11896582)

  • 1. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
    Chung J; Chavez PR; Russell RM; Wang XD
    Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V; Davidson B; Reich R
    Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy.
    Schrum LW; Black D; Iimuro Y; Rippe RA; Brenner DA; Behrns KE
    J Surg Res; 2000 Feb; 88(2):142-9. PubMed ID: 10644480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
    Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK
    Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid inhibits cardiac neural crest migration by blocking c-Jun N-terminal kinase activation.
    Li J; Molkentin JD; Colbert MC
    Dev Biol; 2001 Apr; 232(2):351-61. PubMed ID: 11401397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW; Shi YY; Higgins LS; Orlowski RZ
    Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY; Liu Y; Wu GS
    Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
    Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M
    Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated fasting stress causes activation of mitogen-activated protein kinases (ERK/JNK) in rat liver.
    Nishio H; Kuwabara H; Mori H; Suzuki K
    Hepatology; 2002 Jul; 36(1):72-80. PubMed ID: 12085351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.